Published in Eur J Nutr on June 01, 2004
Evaluation of Lactobacillus coryniformis CECT5711 strain as a coadjuvant in a vaccination process: a randomised clinical trial in healthy adults. Nutr Metab (Lond) (2017) 2.02
Intestinal permeability--a new target for disease prevention and therapy. BMC Gastroenterol (2014) 1.52
Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J Bacteriol (2012) 1.47
Lactobacillus fermentum (PCC®) supplementation and gastrointestinal and respiratory-tract illness symptoms: a randomised control trial in athletes. Nutr J (2011) 1.29
Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients. Microb Ecol (2011) 1.19
'Gut health': a new objective in medicine? BMC Med (2011) 1.15
PASSCLAIM: consensus on criteria. Eur J Nutr (2005) 1.14
Probiotic properties of Lactobacillus rhamnosus and Lactobacillus paracasei isolated from human faeces. Eur J Nutr (2009) 1.11
Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? Genes Nutr (2011) 1.10
Characterization of intestinal inflammation and identification of related gene expression changes in mdr1a(-/-) mice. Genes Nutr (2007) 1.04
Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat. Transl Psychiatry (2013) 1.03
Increasing work-place healthiness with the probiotic Lactobacillus reuteri: a randomised, double-blind placebo-controlled study. Environ Health (2005) 1.02
The human gut mobile metagenome: a metazoan perspective. Gut Microbes (2011) 0.99
Probiotics and gut health: a special focus on liver diseases. World J Gastroenterol (2010) 0.96
Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread. Appl Environ Microbiol (2009) 0.92
The gut-joint axis: cross reactive food antibodies in rheumatoid arthritis. Gut (2006) 0.91
The murine caecal microRNA signature depends on the presence of the endogenous microbiota. Int J Biol Sci (2011) 0.90
Probiotic/synbiotic therapy for treating critically ill patients from a gut microbiota perspective. Dig Dis Sci (2012) 0.90
High-level dietary fibre up-regulates colonic fermentation and relative abundance of saccharolytic bacteria within the human faecal microbiota in vitro. Eur J Nutr (2011) 0.89
Ability of probiotic Lactobacillus casei DN 114001 to bind or/and metabolise heterocyclic aromatic amines in vitro. Eur J Nutr (2009) 0.87
Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut. Mediators Inflamm (2015) 0.87
Some putative prebiotics increase the severity of Salmonella enterica serovar Typhimurium infection in mice. BMC Microbiol (2009) 0.86
Evolutionary, ecological and biotechnological perspectives on plasmids resident in the human gut mobile metagenome. Bioeng Bugs (2012) 0.80
Effect of type of TAG fatty acids on lutein and zeaxanthin bioavailability. Br J Nutr (2012) 0.79
The process for the assessment of scientific support for claims on food. Eur J Nutr (2009) 0.79
Gastrointestinal microbiota and some children diseases: a review. Gastroenterol Res Pract (2012) 0.79
Inflammation in irritable bowel syndrome: Myth or new treatment target? World J Gastroenterol (2016) 0.79
Astragalus root and elderberry fruit extracts enhance the IFN-β stimulatory effects of Lactobacillus acidophilus in murine-derived dendritic cells. PLoS One (2012) 0.78
Probiotic bacteria: a viable adjuvant therapy for relieving symptoms of rheumatoid arthritis. Inflammopharmacology (2016) 0.76
Dietary Fiber and the Human Gut Microbiota: Application of Evidence Mapping Methodology. Nutrients (2017) 0.76
The use of prebiotics during the first year of life for atopy prevention and treatment. Immun Inflamm Dis (2013) 0.76
Immunomodulatory effects of ResistAid™: A randomized, double-blind, placebo-controlled, multidose study. J Am Coll Nutr (2013) 0.76
The prevalence of bacterial contamination of surgical cold sterile solutions from community companion animal veterinary practices in southern Ontario. Can Vet J (2010) 0.75
Maternal Prebiotic Ingestion Increased the Number of Fecal Bifidobacteria in Pregnant Women but Not in Their Neonates Aged One Month. Nutrients (2017) 0.75
Inulin-Type β2-1 Fructans have Some Effect on the Antibody Response to Seasonal Influenza Vaccination in Healthy Middle-Aged Humans. Front Immunol (2015) 0.75
Prebiotic Potential of a Maize-Based Soluble Fibre and Impact of Dose on the Human Gut Microbiota. PLoS One (2016) 0.75
Host-microbiome interaction in Crohn's disease: A familiar or familial issue? World J Gastrointest Pathophysiol (2015) 0.75
A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63
Enterotypes of the human gut microbiome. Nature (2011) 24.36
Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes (2007) 14.12
Prepublication data sharing. Nature (2009) 12.24
Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell (2012) 4.86
The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol (2012) 3.88
The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr (2012) 3.51
Prebiotic effects: metabolic and health benefits. Br J Nutr (2010) 3.49
Critical review: vegetables and fruit in the prevention of chronic diseases. Eur J Nutr (2012) 3.48
Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr (2008) 3.25
The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations. Am J Gastroenterol (2012) 3.11
Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut (2012) 3.09
Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek (2002) 3.09
Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet (2003) 2.92
Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol (2003) 2.72
Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet (2003) 2.68
Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. Atherosclerosis (2010) 2.65
Metagenomic species profiling using universal phylogenetic marker genes. Nat Methods (2013) 2.51
Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr (2008) 2.48
Cardiovascular effects of marine omega-3 fatty acids. Lancet (2010) 2.45
The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol (2011) 2.29
Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev (2005) 2.28
Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol (2012) 2.28
Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. Genome Res (2010) 2.21
Guidelines for the diagnosis and management of cow's milk protein allergy in infants. Arch Dis Child (2007) 2.19
Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol (2005) 2.18
Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr (2011) 2.16
Perioperative immunonutrition in patients undergoing liver transplantation: a randomized double-blind trial. Hepatology (2015) 2.00
Mode of delivery and asthma -- is there a connection? Pediatr Res (2002) 1.99
Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men. Am J Clin Nutr (2006) 1.97
Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med (2004) 1.96
Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr (2008) 1.91
Innate secretory antibodies protect against natural Salmonella typhimurium infection. J Exp Med (2006) 1.91
Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol (2006) 1.89
New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol (2003) 1.88
Lipid-induced intestinal gas retention in irritable bowel syndrome. Gastroenterology (2002) 1.80
Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system. J Antimicrob Chemother (2010) 1.79
Recommendations for probiotic use--2008. J Clin Gastroenterol (2008) 1.76
Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J (2012) 1.73
Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl Environ Microbiol (2007) 1.73
Differential anti-inflammatory effects of phenolic compounds from extra virgin olive oil identified in human whole blood cultures. Nutrition (2005) 1.72
Breast milk: a source of bifidobacteria for infant gut development and maturation? Neonatology (2007) 1.72
Mode of delivery - effects on gut microbiota and humoral immunity. Neonatology (2007) 1.69
Storage conditions of intestinal microbiota matter in metagenomic analysis. BMC Microbiol (2012) 1.64
Monitoring immune modulation by nutrition in the general population: identifying and substantiating effects on human health. Br J Nutr (2013) 1.64
Prebiotics, immune function, infection and inflammation: a review of the evidence. Br J Nutr (2008) 1.63
Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflamm Bowel Dis (2013) 1.63
An update on the use and investigation of probiotics in health and disease. Gut (2013) 1.62
Abdominal distention results from caudo-ventral redistribution of contents. Gastroenterology (2009) 1.62
Microbial contact during pregnancy, intestinal colonization and human disease. Nat Rev Gastroenterol Hepatol (2012) 1.62
Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood (2004) 1.61
Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. J Proteome Res (2009) 1.57
Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. Am J Clin Nutr (2012) 1.57
Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol (2002) 1.56
Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci (2003) 1.53
Evaluation of health care services provided for older adults in primary health care centers and its internal environment. A step towards age-friendly health centers. Saudi Med J (2015) 1.52
Intestinal gas and bloating: effect of prokinetic stimulation. Am J Gastroenterol (2008) 1.52
Rapid chemokine secretion from endothelial cells originates from 2 distinct compartments. Blood (2004) 1.50
Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol (2003) 1.50
Effects of early prebiotic and probiotic supplementation on development of gut microbiota and fussing and crying in preterm infants: a randomized, double-blind, placebo-controlled trial. J Pediatr (2013) 1.50
Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. FEMS Microbiol Ecol (2005) 1.50
Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. Br J Nutr (2012) 1.50
Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Gut (2012) 1.49
Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol (2007) 1.48
Identification of prebiotic fructooligosaccharide metabolism in Lactobacillus plantarum WCFS1 through microarrays. Appl Environ Microbiol (2007) 1.48
Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease. Proc Nutr Soc (2007) 1.47
Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care (2010) 1.47
Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review. Ann Nutr Metab (2009) 1.47
Therapeutic modulation of microbiota-host metabolic interactions. Sci Transl Med (2012) 1.45
Mechanisms of postprandial abdominal bloating and distension in functional dyspepsia. Gut (2013) 1.44
Probiotic intervention in neonates--will permanent colonization ensue? J Pediatr Gastroenterol Nutr (2006) 1.44
Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland. J Clin Microbiol (2005) 1.44
Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr (2005) 1.42
Effect of probiotics and breastfeeding on the bifidobacterium and lactobacillus/enterococcus microbiota and humoral immune responses. J Pediatr (2005) 1.41
Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. Appl Environ Microbiol (2002) 1.41
BJN gets a new sister! Br J Nutr (2012) 1.39
Microbial-gut interactions in health and disease. Prebiotics. Best Pract Res Clin Gastroenterol (2004) 1.37
The scope of the British Journal of Nutrition. Br J Nutr (2012) 1.37
Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol (2002) 1.36
Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods. Br J Nutr (2011) 1.35
Effect of maternal consumption of lactobacillus GG on transfer and establishment of fecal bifidobacterial microbiota in neonates. J Pediatr Gastroenterol Nutr (2006) 1.35
Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr (2008) 1.34
Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study. Br J Nutr (2007) 1.34
Immune modulation by parenteral lipid emulsions. Am J Clin Nutr (2007) 1.33
Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr (2010) 1.33
Gene-environment interactions in chronic inflammatory disease. Nat Immunol (2011) 1.30
Plasma cytokine response during the postprandial period: a potential causal process in vascular disease? Br J Nutr (2005) 1.30
Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am J Clin Nutr (2010) 1.29
Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. Br J Nutr (2010) 1.29
Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies. Eur J Immunol (2005) 1.29
Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods. Curr Opin Biotechnol (2009) 1.28
Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission. Am J Gastroenterol (2008) 1.28